文献速递乳房整形与再造美容整形

圆形和解剖型硅胶乳房假体八年安全性数据

Eight-Year Safety Data for Round and Anatomical Silicone Gel Breast Implants.
PubMed 文献 · Aesthet Surg J · 2018-01-01

这项前瞻性多中心临床研究在法国17个中心为526名接受隆乳和重建手术的女性植入995枚Eurosilicone毛面 cohesiv Cristalline Paragel乳房假体,随访8年。8年内包膜挛缩总体发生率为8.5%,假体破裂的Kaplan-Meier风险为每患者1.4%、每假体0.9%。作者认为该假体在8年内表现出良好的安全性和有效性。

要点

  • 8年内包膜挛缩总体发生率为8.5%,初次隆乳队列每假体Kaplan-Meier风险为8.4%,初次重建队列为18.0%。
  • 8年内假体破裂的Kaplan-Meier风险为每患者1.4%、每假体0.9%,随访期间经外科医生检查发现8例破裂。
  • 初次隆乳和初次重建的实际假体取出/更换率分别为6.0%和13.8%,感染和血清肿的受试者风险率分别为0.6%和0.2%。

核心结论

  • 这项涉及Eurosilicone圆形和解剖型硅胶乳房假体的多中心临床研究表明,该假体在8年内表现出良好的安全性和有效性。

研究设计与样本

  • 前瞻性临床研究,在法国17个中心为526名接受隆乳和重建手术的女性植入995枚Eurosilicone毛面 cohesiv Cristalline Paragel乳房假体。
  • 术后3个月及此后每年记录并发症,随访8年,采用描述性统计和Kaplan-Meier法分析关键并发症。

主要发现

  • 所有队列8年内包膜挛缩发生率为8.5%,初次隆乳队列每假体Kaplan-Meier风险为8.4%,初次重建队列为18.0%。
  • 随访期间经外科医生检查发现8例假体破裂,8年内破裂的Kaplan-Meier风险为每患者1.4%、每假体0.9%。
  • 初次隆乳和初次重建的实际假体取出/更换率分别为6.0%和13.8%。
  • 感染和血清肿的受试者风险率分别为0.6%和0.2%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The safety and efficacy of all medical devices, including breast implants, is important and consistent performance is best shown by undertaking long-term clinical and vigilance studies. Local complications such as capsular contracture and rupture are risks often associated with breast implant surgery. OBJECTIVES: The authors investigate and evaluate the safety and performance of Eurosilicone's (Eurosilicone S.A.S, Apt Cedex, France) Cristalline Paragel breast implants at 8 years postimplantation. METHODS: In this prospective clinical study, 995 Eurosilicone textured cohesive Cristalline Paragel mammary implants were implanted in 526 women undergoing augmentation and reconstructive surgery at 17 centers across France. Complications were recorded at 3 months and annually thereafter for 8 years. Descriptive statistics were used and key complications were analysed using the Kaplan-Meier method. RESULTS: Capsular contracture was reported in 8.5% of implants across all cohorts through 8 years. The Kaplan-Meier risk of capsular contracture (Baker Grade III/IV) per implant was 8.4% in the primary augmentation cohort and 18.0% in the primary reconstruction cohort. Eight implant ruptures were identified by surgeon examination during this follow-up period. The Kaplan-Meier risk of rupture occurring within 8 years postimplantation, across all cohorts, was 1.4% per patient and 0.9% per implant. Actual implant removal rate (explantation/exchange) was 6.0% and 13.8% for primary augmentation and primary reconstruction, respectively. Actual rates of local complications including infection and seroma were low with risk rates of 0.6% and 0.2% by subject. CONCLUSIONS: This multicenter clinical study involving Eurosilicone's silicone gel breast implants in both round and shaped profiles demonstrates an excellent safety and efficacy profile through 8 years.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Duteille F, Perrot P, Bacheley MH, et al. Eight-Year Safety Data for Round and Anatomical Silicone Gel Breast Implants. Aesthet Surg J. 2018. PMID: 29040345. doi:10.1093/asj/sjx117

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。